Connection
Michaela Kollisch-Singule to Tetracyclines
This is a "connection" page, showing publications Michaela Kollisch-Singule has written about Tetracyclines.
|
|
Connection Strength |
|
 |
|
 |
|
0.259 |
|
|
|
-
Meng Q, Wang X, Guo D, Shi C, Gu R, Ma J, Nieman G, Kollisch-Singule M, Luo J, Cooney RN. Nano-chemically Modified Tetracycline-3 (nCMT-3) Attenuates Acute Lung Injury via Blocking sTREM-1 Release and NLRP3 Inflammasome Activation. Shock. 2022 05 01; 57(5):749-758.
Score: 0.205
-
Ma J, Wang X, Gu R, Guo D, Shi C, Kollisch-Singule M, Suo L, Luo J, Meng Q, Cooney RN. PROPHYLACTIC n CMT-3 ATTENUATES SEPSIS-INDUCED ACUTE KIDNEY INJURY IN ASSOCIATION WITH NLRP3 INFLAMMASOME ACTIVATION AND APOPTOSIS. Shock. 2023 06 01; 59(6):922-929.
Score: 0.054